2.4.0.8 HtmlAndXml 198 333 1 true 48 0 false 5 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.kytherabiopharma.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 0010 - Statement - Balance Sheets Sheet http://www.kytherabiopharma.com/role/BalanceSheet Balance Sheets R2.xml false false R3.htm 0015 - Statement - Balance Sheets (Parentheical) Sheet http://www.kytherabiopharma.com/role/BalanceSheetParenthetical Balance Sheets (Parentheical) R3.xml false false R4.htm 0020 - Statement - Statements of Operations and Comprehensive Loss Sheet http://www.kytherabiopharma.com/role/StatementOfIncome Statements of Operations and Comprehensive Loss R4.xml false false R5.htm 0030 - Statement - Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) Sheet http://www.kytherabiopharma.com/role/StatementOfStockholdersEquity Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) R5.xml false false R6.htm 0035 - Statement - Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheical) Sheet http://www.kytherabiopharma.com/role/StatementOfStockholdersEquityParenthetical Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheical) R6.xml false false R7.htm 0040 - Statement - Statements of Cash Flows Sheet http://www.kytherabiopharma.com/role/CashFlows Statements of Cash Flows R7.xml false false R8.htm 1010 - Disclosure - Organization and Basis of Presentation Sheet http://www.kytherabiopharma.com/role/DisclosureOrganizationAndBasisOfPresentation Organization and Basis of Presentation R8.xml false false R9.htm 1020 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies R9.xml false false R10.htm 1030 - Disclosure - Bridge Financing Sheet http://www.kytherabiopharma.com/role/DisclosureBridgeFinancing Bridge Financing R10.xml false false R11.htm 1040 - Disclosure - Note Payable Sheet http://www.kytherabiopharma.com/role/DisclosureNotePayable Note Payable R11.xml false false R12.htm 1050 - Disclosure - Redeemable Convertible Preferred Stock Sheet http://www.kytherabiopharma.com/role/DisclosureRedeemableConvertiblePreferredStock Redeemable Convertible Preferred Stock R12.xml false false R13.htm 1060 - Disclosure - Stockholders' Equity Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquity Stockholders' Equity R13.xml false false R14.htm 1070 - Disclosure - Commitments, Collaborations and Contingencies Sheet http://www.kytherabiopharma.com/role/DisclosureCommitmentsCollaborationsAndContingencies Commitments, Collaborations and Contingencies R14.xml false false R15.htm 1080 - Disclosure - Fair Value Measurements Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements R15.xml false false R16.htm 1090 - Disclosure - 401(k) Savings Plan Sheet http://www.kytherabiopharma.com/role/Disclosure401kSavingsPlan 401(k) Savings Plan R16.xml false false R17.htm 1100 - Disclosure - Income Taxes Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxes Income Taxes R17.xml false false R18.htm 1110 - Disclosure - Selected Quarterly Financial Data (unaudited) Sheet http://www.kytherabiopharma.com/role/DisclosureSelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (unaudited) R18.xml false false R19.htm 1120 - Disclosure - Subsequent Events Sheet http://www.kytherabiopharma.com/role/DisclosureSubsequentEvents Subsequent Events R19.xml false false R20.htm 2020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) R20.xml false false R21.htm 3020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) R21.xml false false R22.htm 3040 - Disclosure - Note Payable (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureNotePayableTables Note Payable (Tables) R22.xml false false R23.htm 3060 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) R23.xml false false R24.htm 3070 - Disclosure - Commitments, Collaborations and Contingencies (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureCommitmentsCollaborationsAndContingenciesTables Commitments, Collaborations and Contingencies (Tables) R24.xml false false R25.htm 3080 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) R25.xml false false R26.htm 3100 - Disclosure - Income Taxes (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) R26.xml false false R27.htm 3110 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureSelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (unaudited) (Tables) R27.xml false false R28.htm 4010 - Disclosure - Organization and Basis of Presentation (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureOrganizationAndBasisOfPresentationDetails Organization and Basis of Presentation (Details) R28.xml false false R29.htm 4020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) R29.xml false false R30.htm 4021 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) R30.xml false false R31.htm 4022 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) R31.xml false false R32.htm 4023 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) R32.xml false false R33.htm 4030 - Disclosure - Bridge Financing (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureBridgeFinancingDetails Bridge Financing (Details) R33.xml false false R34.htm 4040 - Disclosure - Note Payable (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureNotePayableDetails Note Payable (Details) R34.xml false false R35.htm 4050 - Disclosure - Redeemable Convertible Preferred Stock (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureRedeemableConvertiblePreferredStockDetails Redeemable Convertible Preferred Stock (Details) R35.xml false false R36.htm 4060 - Disclosure - Stockholders' Equity (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) R36.xml false false R37.htm 4061 - Disclosure - Stockholders' Equity (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails2 Stockholders' Equity (Details 2) R37.xml false false R38.htm 4062 - Disclosure - Stockholders' Equity (Details 3) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails3 Stockholders' Equity (Details 3) R38.xml false false R39.htm 4063 - Disclosure - Stockholders' Equity (Details 4) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails4 Stockholders' Equity (Details 4) R39.xml false false R40.htm 4070 - Disclosure - Commitments, Collaborations and Contingencies (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureCommitmentsCollaborationsAndContingenciesDetails Commitments, Collaborations and Contingencies (Details) R40.xml false false R41.htm 4071 - Disclosure - Commitments, Collaborations and Contingencies (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureCommitmentsCollaborationsAndContingenciesDetails2 Commitments, Collaborations and Contingencies (Details 2) R41.xml false false R42.htm 4080 - Disclosure - Fair Value Measurements (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) R42.xml false false R43.htm 4081 - Disclosure - Fair Value Measurements (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurementsDetails2 Fair Value Measurements (Details 2) R43.xml false false R44.htm 4090 - Disclosure - 401(k) Savings Plan (Details) Sheet http://www.kytherabiopharma.com/role/Disclosure401kSavingsPlanDetails 401(k) Savings Plan (Details) R44.xml false false R45.htm 4100 - Disclosure - Income Taxes (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxesDetailsDetails Income Taxes (Details) R45.xml false false R46.htm 4101 - Disclosure - Income Taxes (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxesDetailsDetails2 Income Taxes (Details 2) R46.xml false false R47.htm 4110 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureSelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (unaudited) (Details) R47.xml false false R48.htm 4120 - Disclosure - Subsequent Events (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) R48.xml false false All Reports Book All Reports Element kyth_StockIssuedDuringPeriodSharesConversionRatio had a mix of decimals attribute values: 0 5. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 4. Element us-gaap_SharePrice had a mix of decimals attribute values: 0 2. Warning: The equity rendering routine was not applied to 0035 - Statement - Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheical). None of the elements feature the 'periodStartLabel' preferred label role. 'Monetary' elements on report '4023 - Disclosure - Summary of Significant Accounting Policies (Details 4)' had a mix of different decimal attribute values. Process Flow-Through: 0010 - Statement - Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0015 - Statement - Balance Sheets (Parentheical) Process Flow-Through: Removing column 'Aug. 31, 2005 Series A redeemable convertible preferred stock' Process Flow-Through: Removing column 'May 31, 2006 Series B redeemable convertible preferred stock' Process Flow-Through: Removing column 'Jan. 25, 2011 Series C redeemable convertible preferred stock' Process Flow-Through: Removing column 'May 31, 2008 Series C redeemable convertible preferred stock' Process Flow-Through: Removing column 'Aug. 31, 2011 Series D redeemable convertible preferred stock' Process Flow-Through: 0020 - Statement - Statements of Operations and Comprehensive Loss Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 0035 - Statement - Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheical) Process Flow-Through: Removing column '0 Months Ended Oct. 16, 2012' Process Flow-Through: 0040 - Statement - Statements of Cash Flows kyth-20121231.xml kyth-20121231.xsd kyth-20121231_cal.xml kyth-20121231_def.xml kyth-20121231_lab.xml kyth-20121231_pre.xml true true